SCHEMBL9111455

SCHEMBL9111455

[CH2]CSc1cc(OC)c(OC)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 1/20 0.47
▸ ACHE P22303 1/20 0.46
▸ MAPT P10636 2/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ HTR2B P41595 1/20 0.42
▸ CYP1A1 P04798 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP1B1 Q16678 1/20 0.40
▸ TUBB4A P04350 2/20 0.39
▸ TUBB P07437 2/20 0.39
▸ TUBA3C P0DPH7 2/20 0.39
▸ TUBA1B P68363 2/20 0.39
▸ TUBA4A P68366 2/20 0.39
▸ TUBB4B P68371 2/20 0.39
▸ TUBB3 Q13509 2/20 0.39
▸ TUBB2A Q13885 2/20 0.39
▸ TUBB8 Q3ZCM7 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351063 0.81 PTGS2 (0.54) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL12963223 0.78 AR (0.54) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL11162193 0.78 HTR2A (0.55) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL9832718 0.76 PTGS2 (0.44) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL12932841 0.76 PTGS2 (0.44) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL8428069 0.76 ACHE (0.52) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL2545682 0.75 ACHE (0.56) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL5094631 0.75 ACHE (0.56) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL7911729 0.73 CYP1A1 (0.58) PTGS2ACHEMAPTCYP3A4CA9
SCHEMBL900800 0.71 PTGS2 (0.64) PTGS2ACHEMAPTCYP3A4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1114834-A antidiabetic agent OTSUKA PHARMA CO LTD (JP) 1996-01-10 — — CN disclosed
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 — — EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 — — WO disclosed
Send feedback